| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/06/2000 | WO2000000603A2 Modularly constructed rna molecules having two sequence region types |
| 01/06/2000 | WO2000000599A2 Composition for the induction of apoptosis in target cells |
| 01/06/2000 | WO2000000596A1 3'-exonuclease, production and use thereof |
| 01/06/2000 | WO2000000594A2 Human transferases |
| 01/06/2000 | WO2000000588A2 Porcine spinal cord cells and their use in spinal cord repair |
| 01/06/2000 | WO2000000516A1 Novel sugar chain-bonded thrombomodulin-like peptide |
| 01/06/2000 | WO2000000513A1 The human gene krab-np (npaawe05) |
| 01/06/2000 | WO2000000511A1 Monocyte locomotion inhibitory factor |
| 01/06/2000 | WO2000000510A2 Growth factor modulators |
| 01/06/2000 | WO2000000509A2 Peptides for inhibiting hpv e7 proteins |
| 01/06/2000 | WO2000000504A1 Antisense modulation of tnfr1 expression |
| 01/06/2000 | WO2000000503A1 Human az-1 gene, variants thereof and expressed gene products |
| 01/06/2000 | WO2000000470A1 Amino acid derivatives and drugs containing the same as the active ingredient |
| 01/06/2000 | WO2000000214A2 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 01/06/2000 | WO2000000202A1 Method for inhibiting c-jun expression using jak-3 inhibitors |
| 01/06/2000 | WO2000000191A1 Use of cytoprotectants |
| 01/06/2000 | WO2000000185A1 Cloning and uses of the genetic locus bcl-6 |
| 01/06/2000 | WO2000000180A1 Utilization of growth factors for the production of medicaments |
| 01/06/2000 | WO2000000179A1 Solid dispersed preparation of poorly water-soluble drug containing oil, fatty acid or mixtures thereof |
| 01/06/2000 | WO2000000176A1 Microparticle formulation for inhalation |
| 01/06/2000 | WO2000000163A1 Antibodies and compositions for topical use containing same |
| 01/06/2000 | WO1999058565A8 Cystatin-related protein |
| 01/06/2000 | WO1999058133A3 Anti-diarrheal and method for using the same |
| 01/06/2000 | WO1999057270A3 Human receptor molecules |
| 01/06/2000 | WO1999056723A3 Hemoglobine-haptoglobin complexes for targeted drug delivery |
| 01/06/2000 | WO1999055900A3 Gcp |
| 01/06/2000 | WO1999055855A3 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth |
| 01/06/2000 | WO1999055364A3 Proteins that direct the secretion of virulence proteins and vaccines comprising them |
| 01/06/2000 | WO1999051730A3 Mammalian gene encoding tolloid-like protein |
| 01/06/2000 | WO1999051185A3 Human galactosyl transferases |
| 01/06/2000 | WO1999044629A3 Utilization of cd137 in order to promote the proliferation of peripheral monocytes |
| 01/06/2000 | WO1999043829A3 Cell cycle related proteins |
| 01/06/2000 | WO1999029310A3 Regulation of t cell-mediated immunity by tryptophan and its analogs |
| 01/06/2000 | WO1999026663A3 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor |
| 01/06/2000 | WO1999017759A3 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 01/06/2000 | WO1999000137A3 Induction of an activated myeloid dendritic cell phenotype |
| 01/06/2000 | WO1998001460A8 Brca1 compositions and methods for the diagnosis and treatment of breast cancer |
| 01/06/2000 | CA2337999A1 Method for inhibiting c-jun expression using jak-3 inhibitors |
| 01/06/2000 | CA2336554A1 Marburg virus vaccines |
| 01/06/2000 | CA2336162A1 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them |
| 01/06/2000 | CA2335601A1 Porcine spinal cord cells and their use in spinal cord repair |
| 01/06/2000 | CA2334686A1 Use of cytoprotectants |
| 01/06/2000 | CA2334046A1 3'-exonuclease, its preparation and use |
| 01/06/2000 | CA2332571A1 Novel sugar chain-bonded thrombomodulin-like peptide |
| 01/06/2000 | CA2332494A1 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons |
| 01/06/2000 | CA2332379A1 Molecules associated with apoptosis |
| 01/06/2000 | CA2332175A1 Modularly constructed rna molecules having two sequence region types |
| 01/06/2000 | CA2332127A1 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 01/06/2000 | CA2331925A1 Monocyte locomotion inhibitory factor |
| 01/06/2000 | CA2331845A1 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 01/06/2000 | CA2331779A1 Methods and compositions for modulating spermatogenesis |
| 01/06/2000 | CA2331386A1 Human signal peptide-containing proteins |
| 01/06/2000 | CA2331380A1 Human oxidoreductase proteins |
| 01/06/2000 | CA2330565A1 Growth factor modulators |
| 01/06/2000 | CA2330546A1 Immune system molecules |
| 01/06/2000 | CA2330525A1 Human transferases |
| 01/06/2000 | CA2328499A1 A nucleic acid encoding a retinoblastoma binding protein (rbp-7) and polymorphic markers associated with said nucleic acid |
| 01/05/2000 | EP0969093A2 Drug binding protein |
| 01/05/2000 | EP0969091A2 Leptin receptor gene-related protein |
| 01/05/2000 | EP0969017A1 Modified C1-esterase inhibitor for blocking infectivity of HIV |
| 01/05/2000 | EP0969016A2 Glucagon-like peptide and insulinotropin derivates |
| 01/05/2000 | EP0969013A1 Peptides for inhibiting HPV E7 proteins |
| 01/05/2000 | EP0968724A1 Use of viral vectors for treatment of the injured peripheral and central nervous system |
| 01/05/2000 | EP0968723A1 Healing of wounds or fibrotic disorders using at least one agent against a growth factor |
| 01/05/2000 | EP0968721A2 Use of a composition comprising a peptide for the inhibition of HIV |
| 01/05/2000 | EP0968720A2 Gastric emptying-promoting composition |
| 01/05/2000 | EP0968719A2 Enzyme composition capable of forming an oligosaccharide in vivo |
| 01/05/2000 | EP0968707A2 Compositions against acne and inflamed comedones containing serine proteases and one or more calcium salts |
| 01/05/2000 | EP0968648A1 Mammalian nonhuman transgenic animal having a constitutive or inducible expression of the human endonexin II gene or its muteins or its fragments |
| 01/05/2000 | EP0968477A1 Coincidence detection method, products and apparatus |
| 01/05/2000 | EP0968432A1 Growth factor-dependent diseases |
| 01/05/2000 | EP0968304A1 Identification of inhibitors of protein tyrosine kinase 2 |
| 01/05/2000 | EP0968299A1 Rapid production of autologous tumor vaccines by using hsv amplicon vectors |
| 01/05/2000 | EP0968293A1 Staphylococcus 3-dehydroquinate synthase |
| 01/05/2000 | EP0968291A2 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies |
| 01/05/2000 | EP0968290A1 Anti-alphavbeta3 humanized monoclonal antibodies |
| 01/05/2000 | EP0968286A1 Growth factor receptor binding protein |
| 01/05/2000 | EP0968285A1 Morphogenic proteins |
| 01/05/2000 | EP0968284A2 An improved method for the production and purification of adenoviral vectors |
| 01/05/2000 | EP0968281A2 An oncolytic/immunogenic complementary-adenoviral vector system |
| 01/05/2000 | EP0968280A1 Activated vitamin k-dependent blood factor and method for the production thereof |
| 01/05/2000 | EP0968276A1 NOVEL clpL |
| 01/05/2000 | EP0968230A1 Oxidized fragments of apolipoprotein b and their use |
| 01/05/2000 | EP0968229A1 Antigenic peptides reacting with anti-ovary antibodies |
| 01/05/2000 | EP0968228A1 Calcium phosphopeptide complexes |
| 01/05/2000 | EP0968227A1 Dimeric cationic lipids on dicystine basis |
| 01/05/2000 | EP0968226A1 G-rich oligo aptamers and methods of modulating an immune response |
| 01/05/2000 | EP0968225A1 NOVEL spsB |
| 01/05/2000 | EP0968186A1 Improved polyamides for binding in the minor groove of double stranded dna |
| 01/05/2000 | EP0968008A1 A stabilized mixture comprising fibrinogen |
| 01/05/2000 | EP0968002A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
| 01/05/2000 | EP0967998A2 Polymeric carrier |
| 01/05/2000 | EP0967997A1 Pharmaceutical composition for eliminating membrane-mediated cell resistance |
| 01/05/2000 | EP0967996A2 Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactions |
| 01/05/2000 | EP0967994A1 Improved method for treatment and diagnosis of il-5 mediated disorders |
| 01/05/2000 | EP0967992A1 Peptide vaccine to prevent development of several herpes virus infections and/or atherosclerotic plaque |
| 01/05/2000 | EP0967990A1 UDP-N-ACETYLMURAMOYL-L-AIANINE:D-GLUTAMATE LIGASE (murD) OF STAPHYLOCOCCUS AUREUS |
| 01/05/2000 | EP0967989A1 Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same |
| 01/05/2000 | EP0967986A2 USE OF HUMAN alpha 1-ACID GLYCOPROTEIN FOR PRODUCING A PHARMACEUTICAL PREPARATION |
| 01/05/2000 | EP0967983A2 Methods for detection of kaposi's sarcoma-associated herpesvirus-like virus |